Hematological Toxicity in Mice after High Activity Injections of ¹⁷⁷Lu-PSMA-617

• Autori principali: Amanda Kristiansson (Autore), Oskar Vilhelmsson Timmermand (Autore), Mohamed Altai (Autore), Joanna Strand (Autore), Sven-Erik Strand (Autore), Bo Åkerström (Autore), Anders Örbom (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2022-03-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Prostate cancer (PC) is one of the most common malignancies affecting men, with poor prognosis after progression to metastatic castration-resistant prostate cancer (mCRPC). Radioligand therapy (RLT) targeting the overexpressed PSMA on PC cells, with, e.g., ¹⁷⁷Lu-PSMA-617, has...